Table 3. KEGG enrichment analysis of disease mechanisms in SA-AKI.
| Ontology | ID | Description | P value | FDR |
| KEGG_PATHWAY | hsa04668 | TNF signaling pathway | 5.13E-34 | 8.61E-32 |
| KEGG_PATHWAY | hsa05145 | Toxoplasmosis | 1.38E-31 | 1.16E-29 |
| KEGG_PATHWAY | hsa04064 | NF-kappa B signaling pathway | 6.61E-31 | 3.39E-29 |
| KEGG_PATHWAY | hsa04060 | Cytokine-cytokine receptor interaction | 6.61E-31 | 3.39E-29 |
| KEGG_PATHWAY | hsa04610 | Complement and coagulation cascades | 1.01E-30 | 3.39E-29 |
| KEGG_PATHWAY | hsa05200 | Pathways in cancer | 2.62E-30 | 7.33E-29 |
| KEGG_PATHWAY | hsa04380 | Osteoclast differentiation | 6.57E-30 | 1.58E-28 |
| KEGG_PATHWAY | hsa05152 | Tuberculosis | 1.99E-29 | 4.17E-28 |
| KEGG_PATHWAY | hsa04620 | Toll-like receptor signaling pathway | 2.30E-27 | 4.29E-26 |
| KEGG_PATHWAY | hsa05140 | Leishmaniasis | 5.90E-27 | 9.91E-26 |
| KEGG_PATHWAY | hsa04640 | Hematopoietic cell lineage | 1.54E-26 | 2.35E-25 |
| KEGG_PATHWAY | hsa05164 | Influenza A | 4.85E-25 | 6.79E-24 |
| KEGG_PATHWAY | hsa04062 | Chemokine signaling pathway | 6.48E-25 | 8.37E-24 |
| KEGG_PATHWAY | hsa04660 | T cell receptor signaling pathway | 3.49E-23 | 4.19E-22 |
| KEGG_PATHWAY | hsa05133 | Pertussis | 1.03E-22 | 1.15E-21 |
| KEGG_PATHWAY | hsa05142 | Chagas disease (American trypanosomiasis) | 1.17E-22 | 1.22E-21 |
| KEGG_PATHWAY | hsa05161 | Hepatitis B | 2.31E-22 | 2.28E-21 |
| KEGG_PATHWAY | hsa05162 | Measles | 7.21E-22 | 6.73E-21 |
| KEGG_PATHWAY | hsa05321 | Inflammatory bowel disease (IBD) | 1.36E-21 | 1.21E-20 |